LOGIN DASHBOARD

    COVID19

    News

    3 MIN READ

    Nepal finally approves a vaccine for emergency use

    The Record, January 15, 2021, Kathmandu

    Nepal finally approves a vaccine for emergency use

      Share this article

    The government will need more vaccines and the funds to buy them to meet its immunisation goals

    (The Record)

    Nepal’s drug regulatory body has finally approved an anti-Covid-19 vaccine, the Oxford-AstraZeneca vaccine, for emergency use in the country.

    Issuing a notice on Friday, the Department of Drug Administration (DDA), said it had granted conditional permission for emergency use of the Covishield vaccine (the Indian version of the Oxford-AstraZeneca vaccine). The DDA is the drug authority tasked with authorising drugs and vaccines for emergency use in Nepal. 

    In December, to relax provisions related to registering drugs and vaccines for emergency use, the government had amended the Drugs Act through an ordinance. The Act now allows the import of Covid-19 vaccines even if they are not enlisted with the World Health Organization (WHO). 

    Earlier, there was no legal provision to allow emergency use of vaccines in the country. “The relaxed provisions allow the government to vaccinate members of the critical age group and save them from the pandemic,” said Santosh KC, an information officer at the authority. “This has now paved the way for the government to initiate procurement deals with vaccine manufacturers.”

    The Oxford-AstraZeneca vaccine, developed by Oxford University and pharmaceutical company AstraZeneca, has already been authorised for emergency use in the UK and India, while Pfizer and BioNtech and Moderna have been authorised for emergency use in the US. Even though these vaccines are not enlisted with the WHO, they have been approved by the drug regulatory bodies in their respective countries. 

    In India, on Saturday, the Covishield vaccine will be deployed, along with India’s homegrown vaccine, Covaxin, when the country launches the world’s largest vaccination drive. Covishield is manufactured by the Serum Institute of India and Covaxin is manufactured by Bharat Biotech. 

    On January 13, the DDA had issued a notice calling on manufacturers of vaccines and their agents to apply for emergency use authorisation for Nepal. According to KC, the Serum Institute of India, Bharat Biotech, and China’s Sinopharm had responded to the call. The department approved the Serum Institute while rejecting others, citing a lack of necessary data documents. 

    There have been concerns raised over the use of Covaxin, as the media has reported that the vaccine was approved without the manufacturer submitting the necessary efficacy data. And DDA officials said they were not provided the necessary trial data for Sinopharm’s vaccine, Sinovac, and the RFID’s Sputnik V. 

    In September last year, vaccine manufacturers from the UK, China, and Russia had approached Nepal to conduct Phase 3 clinical trials here. But the government was not able to properly respond to them. Had the government inked those deals, many Nepalis would have been already lining up for vaccines by now. 

    The recent approval by the drug authority comes at a time when Nepal’s minister for foreign affairs, Pradeep Kumar Gyawali, has reached New Delhi to attend a meeting of the joint commission.

    During his India visit, Minister Gyawali is expected to discuss the issue of importing anti-corona vaccines. Ahead of Minister Gyawali’s visit, Nepal’s Foreign Affairs Ministry had issued a press statement that said the countries would hold discussions about “Covid-19 cooperation”.

    An estimated 20 million doses is required to inoculate 72 percent of Nepal’s estimated population of 29 million (the vaccine can only be used on people over 18 years of age). 

    Nepal has earmarked NRs 42 billion for its inoculation drive. But the country, which has been reeling under an acute economic crisis because of the Covid-19 pandemic, has no real plans for coming up with the stated budget for procuring vaccines. To make matters worse, amidst this economic crisis, Prime Minister KP Sharma Oli announced a general election for April and May. That election will cost Nepal billions of rupees.

    Thus, to meet the costs of immunising Nepalis, the government has appealed to international donor agencies, non-governmental organisations, and philanthropic institutions to contribute to Nepal’s immunisation fund.  

    :::::::



    author bio photo

    The Record  We are an independent digital publication based in Kathmandu, Nepal. Our stories examine politics, the economy, society, and culture. We look into events both current and past, offering depth, analysis, and perspective. Explore our features, explainers, long reads, multimedia stories, and podcasts. There’s something here for everyone.



    Comments

    Get the best of

    the Record

    Previous Next

    YOU MAY ALSO LIKE

    COVID19

    News

    2 min read

    Daily Covid infections cross the 2,000 mark

    The Record - September 18, 2020

    Two days after the end of lockdown, the spread of coronavirus has passed a new threshold

    Interviews

    12 min read

    From politics to poetry: Kedar Man Vyathit

    Uttam Kunwar - May 5, 2020

    Vyathit was a prolific poet who wrote in Nepali, Newari and Hindi languages

    Features

    13 min read

    The long, elusive wait for justice

    Tufan Neupane - November 24, 2020

    For the victims of war-era atrocities to whom Nepal has continually shown an unwillingness to deliver justice, a bleak future awaits

    COVID19

    Features

    4 min read

    The race to trial Covid-19 vaccines in Nepal

    The Record - September 13, 2020

    Three countries are courting Nepal to conduct anti-corona vaccines here, but experts caution Nepal to proceed carefully

    Features

    4 min read

    New mandate could help provide some succour to nurses being exploited by private hospitals

    The Record - October 14, 2020

    Hospitals that don’t abide by the MoHP’s directive won’t be able to continue operating

    COVID19

    Features

    3 min read

    Nepal confirms record increase of 5,008 new infections in a single day

    The Record , Record Nepal - October 10, 2020

    The infection count could double in 20 days--such numbers could break the country’s health system

    Features

    6 min read

    Upendra Mahato made millions and paid almost no taxes

    Rudra Pangeni , Deepak Adhikari - January 5, 2021

    Through sales of his Ncell shares, Mahato possibly made over $400 million and paid almost none of the capital gains tax he was supposed to

    Features

    6 min read

    Oli has scheduled an election for spring but prospects are slim

    Bhadra Sharma - January 8, 2021

    A series of constitutional, political, logistical, and temporal constraints will have to be resolved if a legitimate election is to be held in spring

    • About
    • Contributors
    • Jobs
    • Contact

    CONNECT WITH US

    © Copyright the Record | All Rights Reserved | Privacy Policy